Andrew H. Galligan
Director, Diadexus, Inc.
Companies
- Arcellx, Inc.Board member Mar 20, 2025 to now1
- OomaBoard member Jul 16, 2015 to now2
- NEVRO CORPChief financial officer Nov 5, 2014 to Jun 8, 20203
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Ooma OOMA250,824 shares4$4.9M at $19.35Jun 4, 2026- Arcellx, Inc.0 shares5Apr 28, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Jun 4, 2026Granted 9,743 shares of Ooma4
- Apr 28, 2026U 5,000 shares of Arcellx, Inc.5
- Jun 23, 2025Sold 12,407 shares at $12.43 of Ooma6
- Jun 5, 2025Granted 11,556 shares of Ooma7
- Dec 17, 2024Sold 14,824 shares at $14.56 of Ooma8
- Dec 17, 2024Exercised options 35,000 shares at $6.04 of Ooma8
- Jun 6, 2024Granted 19,762 shares of Ooma9
- Jun 1, 2023Granted 11,783 shares of Ooma10
- Jun 1, 2022Granted 11,355 shares of Ooma11
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARArcellx, Inc., Board member
- 2SEC EDGAROoma, Board member
- 3SEC EDGARNEVRO CORP, Chief financial officer
- 4
- 5
- 6SEC EDGARForm 4 filed Jun 24, 2025
- 7SEC EDGARForm 4 filed Jun 9, 2025
- 8SEC EDGARForm 4 filed Dec 19, 2024
- 9SEC EDGARForm 4 filed Jun 7, 2024
- 10SEC EDGARForm 4 filed Jun 5, 2023
- 11SEC EDGARForm 4 filed Jun 3, 2022